The Current Ratio as of June 2026 (TTM) for Entasis Therapeutics Holdings Inc. (ETTX) is 4.10

According to Entasis Therapeutics Holdings Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.10. This represents a change of -4.78% compared to the average of 4.31 of the last 4 quarters.

Entasis Therapeutics Holdings Inc. (ETTX) Historical Current Ratio (quarterly & annually)

How has ETTX Current Ratio performed in the past?

The mean historical Current Ratio of Entasis Therapeutics Holdings Inc. over the last ten years is 7.16. The current 4.10 Current Ratio has changed 5.62% with respect to the historical average. Over the past ten years (40 quarters), ETTX's Current Ratio was at its highest in in the December 2018 quarter at 14.28. The Current Ratio was at its lowest in in the September 2017 quarter at 0.

Entasis Therapeutics Holdings Inc. (ETTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Entasis Therapeutics Holdings Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Entasis Therapeutics Holdings Inc. (ETTX) Average Current Ratio

How has ETTX Current Ratio performed in the past?

The current Current Ratio of Entasis Therapeutics Holdings Inc. (ETTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Entasis Therapeutics Holdings Inc. (ETTX) Current Ratio vs. Peers

How is ETTX’s Current Ratio compared to its peers?

Entasis Therapeutics Holdings Inc.’s Current Ratio is less than HilleVax, Inc. (26.39), less than Jounce Therapeutics, Inc. (8.37), less than Cyteir Therapeutics, Inc. (28.07), greater than RVL Pharmaceuticals plc (2.89), less than Opiant Pharmaceuticals, Inc. (10.10), less than Tourmaline Bio, Inc. (24.68), greater than Paratek Pharmaceuticals, Inc. (3.66), less than Aadi Bioscience, Inc. (11.36), less than Decibel Therapeutics, Inc. (4.81), less than Miromatrix Medical Inc. (5.52),

Build a custom stock screener for Entasis Therapeutics Holdings Inc. (ETTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entasis Therapeutics Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Entasis Therapeutics Holdings Inc. (ETTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Entasis Therapeutics Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.